Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Public Employees Retirement Association of Colorado

Public Employees Retirement Association of Colorado decreased its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 5.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,725 shares of the biotechnology company’s stock after selling 463 shares during the quarter. Public Employees Retirement Association of Colorado’s holdings in Axon Enterprise were worth $2,417,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of AXON. BOKF NA raised its position in shares of Axon Enterprise by 52.7% during the 1st quarter. BOKF NA now owns 9,465 shares of the biotechnology company’s stock worth $2,947,000 after purchasing an additional 3,268 shares during the period. Hood River Capital Management LLC grew its stake in Axon Enterprise by 7.2% during the 1st quarter. Hood River Capital Management LLC now owns 213,724 shares of the biotechnology company’s stock worth $66,870,000 after buying an additional 14,330 shares during the last quarter. 1832 Asset Management L.P. acquired a new stake in Axon Enterprise in the first quarter worth $81,630,000. Quadrature Capital Ltd acquired a new position in shares of Axon Enterprise during the first quarter valued at $12,191,000. Finally, JT Stratford LLC acquired a new position in shares of Axon Enterprise during the first quarter valued at $212,000. Institutional investors own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on AXON shares. Craig Hallum upped their price target on shares of Axon Enterprise from $325.00 to $370.00 and gave the stock a “buy” rating in a research report on Tuesday, May 7th. Jefferies Financial Group began coverage on Axon Enterprise in a report on Wednesday, July 17th. They set a “buy” rating and a $385.00 price target on the stock. Bank of America started coverage on Axon Enterprise in a report on Wednesday, July 17th. They issued a “buy” rating and a $380.00 price objective for the company. Morgan Stanley lifted their target price on Axon Enterprise from $285.00 to $310.00 and gave the company an “equal weight” rating in a research note on Friday, April 26th. Finally, William Blair reaffirmed an “outperform” rating on shares of Axon Enterprise in a research note on Wednesday, April 24th. Two analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $342.54.

Axon Enterprise Stock Performance

Shares of AXON stock opened at $309.00 on Tuesday. The company has a market capitalization of $23.32 billion, a price-to-earnings ratio of 90.35, a P/E/G ratio of 7.00 and a beta of 0.95. Axon Enterprise, Inc. has a 1-year low of $175.37 and a 1-year high of $329.87. The company has a current ratio of 2.91, a quick ratio of 2.55 and a debt-to-equity ratio of 0.37. The stock’s fifty day simple moving average is $294.83 and its 200-day simple moving average is $292.75.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Friday, May 10th. The biotechnology company reported $1.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.95 by $0.20. Axon Enterprise had a net margin of 15.60% and a return on equity of 11.71%. The company had revenue of $460.74 million during the quarter, compared to the consensus estimate of $441.57 million. During the same quarter in the prior year, the firm earned $0.51 EPS. The company’s revenue was up 34.3% compared to the same quarter last year. On average, sell-side analysts predict that Axon Enterprise, Inc. will post 2.35 earnings per share for the current fiscal year.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, President Joshua Isner sold 44,000 shares of the business’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $309.96, for a total value of $13,638,240.00. Following the transaction, the president now owns 275,843 shares in the company, valued at $85,500,296.28. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Axon Enterprise news, President Joshua Isner sold 44,000 shares of Axon Enterprise stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $309.96, for a total value of $13,638,240.00. Following the completion of the sale, the president now directly owns 275,843 shares in the company, valued at $85,500,296.28. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Julie A. Cullivan sold 993 shares of the company’s stock in a transaction on Friday, May 31st. The stock was sold at an average price of $281.72, for a total transaction of $279,747.96. Following the completion of the sale, the director now owns 4,553 shares of the company’s stock, valued at $1,282,671.16. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 89,447 shares of company stock valued at $27,684,677. Insiders own 6.10% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.